ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0914

Transcription Factor RFX1 Promotes M1 Macrophage Polarization in Systemic Lupus Erythematosus via Regulating APOBEC3A

shuang Yang1, Pei Du1, Sujie Jia2 and Ming Zhao2, 1Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital of Central South University, Changsha, China, 2Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China

Meeting: ACR Convergence 2023

Keywords: Epigenetics, macrophages, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (0899–0933) SLE – Etiology & Pathogenesis Poster

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Aberrant macrophage polarization is generally present in autoimmune diseases. Overwhelming M1 macrophage induces the continuous progression of inflammation, which is one of the vital reasons for the development of autoimmune diseases. However, the underlying mechanism is still unclear. This study mainly explores the role of regulation factor X1 (RFX1) on macrophage polarization in systemic lupus erythematosus (SLE), and elucidates the mechanism of RFX1 regulating abnormal macrophage polarization.

Methods: Western blot (WB) was used to detect RFX1 expression in CD14+ monocyte-derived macrophage (hMDMs) and mouse peritoneal macrophages (PMAs). The conditional knockout mice-Rfx1f/fLyz2-Cre (CKO) was constructed to inhibit RFX1 expression specifically in macrophages. The RNA-seq was used to detect the differently expressed genes in RFX1-overexpressed or knockout PMAs. The expression levels of macrophage markers and pro-inflammatory cytokines in macrophages were detected by RT-qPCR, Flow cytometry or ELISA. The CKO and WTmice with colitis or lupus-like symptom were induced by dextran sulfate sodium (DSS) or IMQ respectively. The damage of intestinal or kidney tissue was examined by H&E staining. The infiltrations of CD45+, neutrophils, macrophages, CD4+ and CD8+ cells in colon or kidney were detected by flow cytometry, as well as markers of M1 and M2 subtypes. ChIP-seq was used to screen the target genes regulated by RFX1.

Results: The protein expression of RFX1 was increased significantly in LPS induced M1 macrophage. Compared with control group, the expressions of M1-related genes were increased in RFX1-overexpressed PMAs, while the expressions were significantly reduced in Rfx1-deficient PMAs. We also found that the relative mRNA and protein expression of RFX1 in CD14+ monocyte from the peripheral blood of SLE patients was significantly increased compared with healthy control (HC).

In addition, deficiency of Rfx1 protect the integrity of the intestinal structure in colitis mice and inhibited the damage to kidney from lupus-like mice. The infiltration of immune cells was obviously reduced in colon or kidney form CKO mice. The M1-related gene expression such CD86 or MHCII was decreased in macrophages from CKO mice. Besides, the concentrations of pro-inflammatory cytokines including Il-6 and Tnf-a and Il-1b were lessened significantly in serum from CKO mice.

Dual luciferase reporter and ChIP-qPCR assay indicated that APOBEC3A transcription was regulated by RFX1 directly. And the methylation of IL6 and TNF promoter in macrophage was decreased by APOBEC3A or RFX1 overexpression. Besides, the methylation of IL6 and TNF promoter were also decreased in monocyte and macrophage from SLE patients.

Conclusion: Both in vitro and in vivo experiments show that RFX1 promotes M1 polarization by APOBEC3A-mediated demethylation. And RFX1 may promoted the autoimmune inflammation in SLE.


Disclosures: s. Yang: None; P. Du: None; S. Jia: None; M. Zhao: None.

To cite this abstract in AMA style:

Yang s, Du P, Jia S, Zhao M. Transcription Factor RFX1 Promotes M1 Macrophage Polarization in Systemic Lupus Erythematosus via Regulating APOBEC3A [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/transcription-factor-rfx1-promotes-m1-macrophage-polarization-in-systemic-lupus-erythematosus-via-regulating-apobec3a/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/transcription-factor-rfx1-promotes-m1-macrophage-polarization-in-systemic-lupus-erythematosus-via-regulating-apobec3a/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology